Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronen Brenner

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|July 29, 2025
Exploring the Impact of TP53 Mutation and Wild-Type Status on the Efficacy of Immunotherapy in Non-Small Cell Lung CancerAlexander Yakobson, Ronen Brenner, Itamar Gothelf, et al.
Cancers|March 28, 2025
Is the Addition of Chemotherapy to Adjuvant Radiation in Merkel Cell Cancer Beneficial? Real-World Data with Long-Term Follow-UpWalid Shalata, Hanna T Frumin Edri, Ina Sarel, et al.
Frontiers in Molecular Biosciences|May 11, 2026
Variant allele frequency as a predictor of treatment response to osimertinib in EGFR-mutated NSCLCWalid Shalata, Bilal Krayim, Asmah Miari, et al.
Frontiers in Immunology|December 8, 2025
Worse prognosis of local and locally advanced head and neck Merkel cell carcinoma: Is it time to change the treatment paradigm?Ronen Brenner, Hanna T Frumin Edri, Ina Sarel, et al.
Diagnostics (Basel, Switzerland)|March 14, 2026
Sun-Exposed vs. Non-Sun-Exposed Areas: Epidemiology and Pathogenesis of Non-Metastatic Merkel Cell CarcinomaAlexander Yakobson, Ronen Brenner, Hanna T Frumin Edri, et al.
Diseases (Basel, Switzerland)|October 24, 2023
Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic TreatmentsAbed Agbarya, Ina Sarel, Tomer Ziv-Baran, et al.
Frontiers in Molecular Biosciences|July 9, 2026
Impact of EGFR variant allele frequency on treatment-related adverse events in patients with metastatic NSCLC treated with osimertinibWalid Shalata, Bilal Krayim, Asmah Miari, et al.
International Journal of Molecular Sciences|February 13, 2026
Impact of Statin Use on Immunotherapy Outcomes and Efficacy in Non-Small Cell Lung Cancer PatientsAlexander Yakobson, Abed Agbarya, Yulia Dudnik, et al.
World Journal of Gastroenterology|November 3, 2011
MicroRNAs as a potential prognostic factor in gastric cancerBaruch Brenner, Moshe B Hoshen, Ofer Purim, et al.
Cancers|August 28, 2025
Analysis of Metastases and Second Primary Malignancy Development in Patients with Invasive Transitional Cell Carcinoma of the BladderKeren Rouvinov, Alexander Yakobson, Angela Tiganas, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|July 29, 2025
Exploring the Impact of TP53 Mutation and Wild-Type Status on the Efficacy of Immunotherapy in Non-Small Cell Lung CancerAlexander Yakobson, Ronen Brenner, Itamar Gothelf, et al.
Cancers|March 28, 2025
Is the Addition of Chemotherapy to Adjuvant Radiation in Merkel Cell Cancer Beneficial? Real-World Data with Long-Term Follow-UpWalid Shalata, Hanna T Frumin Edri, Ina Sarel, et al.
Frontiers in Molecular Biosciences|May 11, 2026
Variant allele frequency as a predictor of treatment response to osimertinib in EGFR-mutated NSCLCWalid Shalata, Bilal Krayim, Asmah Miari, et al.
Frontiers in Immunology|December 8, 2025
Worse prognosis of local and locally advanced head and neck Merkel cell carcinoma: Is it time to change the treatment paradigm?Ronen Brenner, Hanna T Frumin Edri, Ina Sarel, et al.
Diagnostics (Basel, Switzerland)|March 14, 2026
Sun-Exposed vs. Non-Sun-Exposed Areas: Epidemiology and Pathogenesis of Non-Metastatic Merkel Cell CarcinomaAlexander Yakobson, Ronen Brenner, Hanna T Frumin Edri, et al.
Diseases (Basel, Switzerland)|October 24, 2023
Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic TreatmentsAbed Agbarya, Ina Sarel, Tomer Ziv-Baran, et al.
Frontiers in Molecular Biosciences|July 9, 2026
Impact of EGFR variant allele frequency on treatment-related adverse events in patients with metastatic NSCLC treated with osimertinibWalid Shalata, Bilal Krayim, Asmah Miari, et al.
International Journal of Molecular Sciences|February 13, 2026
Impact of Statin Use on Immunotherapy Outcomes and Efficacy in Non-Small Cell Lung Cancer PatientsAlexander Yakobson, Abed Agbarya, Yulia Dudnik, et al.
World Journal of Gastroenterology|November 3, 2011
MicroRNAs as a potential prognostic factor in gastric cancerBaruch Brenner, Moshe B Hoshen, Ofer Purim, et al.
Cancers|August 28, 2025
Analysis of Metastases and Second Primary Malignancy Development in Patients with Invasive Transitional Cell Carcinoma of the BladderKeren Rouvinov, Alexander Yakobson, Angela Tiganas, et al.
Pageof 6